Israel Active

Technion Professor Shenhav Shemer has joined DREAMS ((Drug REpurposing and Artificial intelligence for Muscular disorderS), a European Union-funded project to discover treatments for rare neuromuscular disorders such as muscular dystrophy, suffered by some 400,000.

A new platform, called LIV, developed at Israel’s Sheba Hospital in the wake of Oct 7, streamlines intake of patients for mental healthcare. LIV’s GenAI (generative artificial intelligence) “converses” with a prospective patient to generate possible diagnoses and treatment recommendations.

Tel Aviv’s Sourasky (Ichilov) Medical Center has partnered with Israel’s NeuroBrave to develop brain-computer interface (BCI) solutions for both complex neurological conditions and patient care. One example is to translate a non-communicative patient’s brainwaves into speech.

The US FDA has granted Fast-Track Designation to the groundbreaking antimicrobial peptide OMN6 from Israel’s Omnix Medical (see previously). OMN6 is commencing a Phase II trial in patients with two deadly hospital-acquired pneumonias - HABP and VABP.

Israel’s BrainsWay’s has published another positive study of 247 depression patients receiving its Deep Transcranial Magnetic Stimulation treatment. 60% went into remission and 80% had a positive response. The results confirmed a 2023 study of 1,350 patients.

The number of Israelis aged 75 and over is growing by about 9,000 individuals per year. Life expectancy in Israel is 85 years for women and 82 years for men and continues to increase. Currently some 346,000 people receive elderly care benefits (e.g. home caregiver) as compared to about 180,000 in 2018.

Israel’s XRHealth (see previously) is to deploy its VR/AR solution in a specially equipped “quiet room” at every police station throughout Israel. It aims to promote mental health resilience, decrease stress, anxiety, and aggression, and improve performance.

Ben Gurion University scientists have just published the results of their work reported in 2019. In trying to develop a biologic remedy to reduce the methane produced by cows, they have uncovered a war in the intestines between good and bad bacteria and a probiotic toxin that tries to mediate.

Researchers at Israel’s Ben Gurion University have developed a nanometer size polymer containing a peptide for delivering chemotherapy. In lab tests, it was over 50% successful in destroying resistant liver metastases (secondary cancer) materialized from colorectal cancer.

A study of 23 progressive multiple sclerosis patients at Hadassah Hospital Ein Kerem highlighted significant beneficial effects of repeated stem cell injections. They improved neurological function, cognition, and quality of life with no adverse effects.